Yvonne Walcott
Psychiatric/Mental Health · Atlanta, GANPI 1073104022
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 87 payments — averaging $102.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- AstraZeneca$588
- Amgen$580
- Neurocrine Biosciences, Inc.$535
- Scpharmaceuticals Inc.$522
- Alkermes, Inc.$481
- plus $5K from 25 others
What the payments were for
- Food & beverage$8,911100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $1,086 |
| AstraZeneca | 6 | $588 |
| Amgen(2 entities) | 5 | $580 |
| Neurocrine Biosciences, Inc. | 6 | $535 |
| Scpharmaceuticals Inc. | 4 | $522 |
| Alkermes, Inc. | 5 | $481 |
| AbbVie | 4 | $461 |
| Boston Scientific | 6 | $456 |
| Axsome Therapeutics, Inc. | 4 | $367 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $324 |
| Impel Pharmaceuticals Inc. | 3 | $306 |
| Sanofi-aventis U.S. LLC | 3 | $290 |
| Bayer | 2 | $281 |
| Johnson & Johnson | 1 | $248 |
| Gilead | 2 | $247 |
| Otsuka America Pharmaceutical, Inc. | 2 | $232 |
| Viiv Healthcare Company | 2 | $228 |
| Scynexis, Inc. | 2 | $197 |
| Coloplast | 3 | $178 |
| E.r. Squibb & Sons, L.L.C. | 2 | $146 |
| Grifols USA, LLC | 1 | $136 |
| Alpha Cognition USA, Inc. | 1 | $125 |
| Urovant Sciences Inc | 1 | $124 |
| Boehringer Ingelheim | 1 | $120 |
| Kowa Pharmaceuticals America, Inc. | 1 | $120 |
| Supernus Pharmaceuticals, Inc. | 1 | $113 |
| Novo Nordisk | 1 | $108 |
| Exact Sciences | 1 | $83 |
| Idorsia Pharmaceuticals US Inc | 2 | $78 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $77 |
| GSK | 1 | $74 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,911 in reported general payments places this provider in the 95th percentile of 900 psychiatric/mental health providers in Georgia.
Other psychiatric/mental health in Atlanta
- Brittany ToliverAtlanta$9K
- Patricia DareAtlanta$7K
- Melanie HackneyAtlanta$6K
- Beverly PhilsonAtlanta$6K
- Rosalid KimaniAtlanta$5K
- Phyillis Kennedy-HowellBarney$673K
- Jessica OliverThomasville$233K
- Sherri KrollBrunswick$155K
- Taylor LeblancAlbany$48K
- Greta HeckmannDalton$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.